A Phase 3, Open-label, Multicenter, Long-term Study to Evaluate the Safety, Efficacy and Pharmacokinetics of TAK-536 in Pediatric Patients 6 to Less Than 16 Years of Age With Hypertension
收藏DataCite Commons2025-10-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007571/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the safety of administration of azilsartan in
pediatric patients aged 6 to less than 16 years with hypertension.
本研究旨在评估阿齐沙坦（azilsartan）用于6岁至不满16岁高血压儿科患者的给药安全性。
提供机构：
Vivli
创建时间：
2021-12-22
